Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma Group (MREO) Current Leases: 2020-2025

Historic Current Leases for Mereo BioPharma Group (MREO) over the last 2 years, with Sep 2025 value amounting to $397,000.

  • Mereo BioPharma Group's Current Leases fell 46.06% to $397,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $397,000, marking a year-over-year decrease of 46.06%. This contributed to the annual value of $707,000 for FY2024, which is 8.44% up from last year.
  • As of Q3 2025, Mereo BioPharma Group's Current Leases stood at $397,000, which was down 33.94% from $601,000 recorded in Q2 2025.
  • In the past 5 years, Mereo BioPharma Group's Current Leases registered a high of $2.7 million during Q2 2021, and its lowest value of $397,000 during Q3 2025.
  • Its 3-year average for Current Leases is $647,625, with a median of $670,500 in 2024.
  • In the last 5 years, Mereo BioPharma Group's Current Leases crashed by 80.34% in 2021 and then grew by 15.60% in 2023.
  • Over the past 5 years, Mereo BioPharma Group's Current Leases (Quarterly) stood at $838,463 in 2021, then crashed by 32.73% to $564,000 in 2022, then grew by 15.60% to $652,000 in 2023, then rose by 8.44% to $707,000 in 2024, then tumbled by 46.06% to $397,000 in 2025.
  • Its Current Leases stands at $397,000 for Q3 2025, versus $601,000 for Q2 2025 and $747,000 for Q1 2025.